The oncolytic activity of Clostridium novyi nontoxic spores in breast cancer

Abedi Jafari, Fatemeh and Abdoli, Asghar and Pilehchian, Reza and Soleimani, Neda and Hosseini, Seyed Masoud (2021) The oncolytic activity of Clostridium novyi nontoxic spores in breast cancer. BioImpacts. ISSN 2228-5660

[thumbnail of bi-12-405.pdf] Text
bi-12-405.pdf - Published Version

Download (2MB)

Abstract

Introduction: Hypoxia context is highly specific for tumors and represents a unique niche which is not found elsewhere in the body. Clostridium novyi is an obligate anaerobic bacterium. It has a potential to treat tumors. The aim of this study was to produce the C. novyi nontoxic spores and to investigate its oncolytic effect on breast cancer in mice model.
Methods: Primarily, the lethal toxin gene in C. novyi type B was removed. Colonies were isolated using PCR testing. To assure the removal of alpha-toxin, plasmid extraction and in vivo assay were conducted. Next, to treat breast cancer model in different sizes of tumors, a single dose of spores of C. novyi nontoxic was tested.
Results: The results denoted that C. novyi nontoxic lost lethal toxin and a­­ppeared to be safe. For smaller than 1000 mm3 tumors, a single dose of C. novyi nontoxic was able to cure 100% of mice bearing breast tumors. Hence the mice remained free of tumor relapse. Tumors larger than 1000 mm3 were not cured by a single dose­ of C. novyi nontoxic treatment.
Conclusion: The experiment concluded that the C. novyi nontoxic might be a suitable and safe candidate, a novel therapeutic approach to encounter such hypoxic regions in the center of tumors. Research also showed that bacteriolytic therapy by C. novyi nontoxic could lead to regression in small tumor.

Item Type: Article
Subjects: Afro Asian Library > Medical Science
Depositing User: Unnamed user with email support@afroasianlibrary.com
Date Deposited: 30 Mar 2023 08:40
Last Modified: 12 Aug 2024 11:54
URI: http://classical.academiceprints.com/id/eprint/386

Actions (login required)

View Item
View Item